The electrochemical modification of clenbuterol for biosensors of dopamine, norepinephrine, adrenalin, ascorbic acid and uric acid at paraffin-impregnated graphite electrode.

Biosens Bioelectron

Anhui Key Laboratory of Controllable Chemistry Reaction & Material Chemical Engineering, Hefei, PR China.

Published: December 2008

The electrochemical modification of clenbuterol (CLB) was studied at paraffin-impregnated graphite electrode (WGE) in two potential ranges of 0.0-1.6V and -1.2 to 1.2V. Various methods including X-ray photoelectron spectroscopy (XPS), UV-spectroelectrochemistry, infrared (IR) spectra and electrochemical techniques have been used to characterizing the modification. Clenbuterol can be modified at the electrode surface by carbon-nitrogen linkage or carbon-carbon linkage in 0.0-1.6V or -1.2 to 1.2V, respectively. The electrochemical behaviors of dopamine (DA), norepinephrine (NE), adrenalin (EP), ascorbic acid (AA) and uric acid (UA) were studied at clenbuterol-modified paraffin-impregnated graphite electrode (CLB/WGE), and it was found that all these compounds could be detected successfully.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2008.06.028DOI Listing

Publication Analysis

Top Keywords

modification clenbuterol
12
paraffin-impregnated graphite
12
graphite electrode
12
electrochemical modification
8
dopamine norepinephrine
8
norepinephrine adrenalin
8
adrenalin ascorbic
8
ascorbic acid
8
acid uric
8
uric acid
8

Similar Publications

Insights into the management of Lewy body dementia: a scoping review.

Ann Med Surg (Lond)

February 2024

Department of Family Medicine, College of Medicine and Health sciences, United Arab Emirates University, Abu Dhabi, United Arab Emirates.

Lewy body dementia (LBD) is situated at the convergence of neurodegenerative disorders, posing an intricate and diverse clinical dilemma. The accumulation of abnormal protein in the brain, namely, the Lewy body causes disturbances in typical neural functioning, leading to a range of cognitive, motor, and mental symptoms that have a substantial influence on the overall well-being and quality of life of affected individuals. There is no definitive cure for the disease; however, several nonpharmacological and pharmacological modalities have been tried with questionable efficacies.

View Article and Find Full Text PDF

Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer's Disease.

Biomater Res

October 2023

Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd, Taipei, 10617, Taiwan.

Background: Alzheimer's disease is a neurodegenerative disorder, and Aβ aggregation is considered to be the central process implicated in its pathogenesis. Current treatments are faced by challenges such as serious side effects and reduced drug bioavailability. In this study, we developed a drug delivery system for intramuscular injection that uses cellular activity to achieve constant and long-term drug release.

View Article and Find Full Text PDF

A facile in-tube solid phase microextraction (in-tube SPME) procedure was developed to enrich ractopamine before HPLC-UV analysis. This was achieved by employing amide groups modified polysaccharide-silica hybrid monolith as an efficient sorbent. The monolith was synthesized by a simple reaction with agarose oxide and tetramethoxylisane, followed by the modification of amide groups via subsequent ring opening, "thiol-ene" click and dehydration reactions.

View Article and Find Full Text PDF

Developing a Simple Immunochromatography Assay for Clenbuterol with Sensitivity by One-Step Staining.

J Agric Food Chem

December 2020

College of Food Science and Engineering, Northwest A&F University, 22 Xinong Road, Yangling, Shaanxi 712100, China.

An innovative lateral flow competition immunoassay (LFCIA) for detecting clenbuterol (CL) was developed by employing the advantages of the coomassie brilliant blue (CBB) staining method. An antibody stained by CBB was used both as a recognition reagent and as a chromogenic probe, enabling the simple but sensitive LFCIA of CL. The CBB-based LFCIA exhibited sensitivity for CL with a detection limit of 2 ng mL.

View Article and Find Full Text PDF

Direct Analysis of Doping Agents in Raw Urine Using Hydrophobic Paper Spray Mass Spectrometry.

J Am Soc Mass Spectrom

June 2020

Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Avenue, Columbus, Ohio 43210, United States.

In this study, the direct analysis of doping agents in urine samples with no sample preparation by a modified paper spray mass spectrometry (PS-MS) methodology has been demonstrated for the first time. We have described a paper surface treatment with trichloromethylsilane using a gas-phase reaction to increase the ionization of target compounds. This approach was applied for the analysis of two classes of banned substances in urine samples: anabolic agents (trenbolone and clenbuterol) and diuretics (furosemide and hydrochlorothiazide).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!